Isolated port-site metastases after minimally invasive hysterectomy for endometrial cancer: outcomes of patients treated with radiotherapy

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Jonathan Douglas GrantAnn H Klopp

Abstract

The management and prognosis of isolated port-site metastases after laparoscopic surgery for endometrial cancer is poorly understood and rarely described in the literature. We report a series of cases treated with radiotherapy to better characterize outcomes in these patients. We retrospectively reviewed medical records of patients with endometrial cancer who developed isolated port-site metastases and were treated with radiation therapy at MD Anderson Cancer Center from 1996 to 2013. Seven patients met these criteria for whom treatment and outcome data were collected. The median interval from initial surgery to port-site recurrence was 15 months. Recurrent tumor size varied from 0.5 to 9 cm as measured on axial imaging. Six of the 7 patients underwent surgical resection of the recurrence. All received radiotherapy to a dose of 45 to 66 Gy. At a median follow-up of 2 years from the time of the port-site recurrence, the rate of disease-free survival at 1 and 2 years after the recurrence was 100% and 44%, respectively. The rate of local control and overall survival at 2 years was 100%. Isolated port-site metastases in the setting of endometrial cancer are associated with high rates of local control when treated with multimodality...Continue Reading

References

Dec 1, 1992·Fertility and Sterility·B Patsner, M Damien
Dec 31, 1997·British Journal of Obstetrics and Gynaecology·N Kadar
Dec 8, 1998·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·M A ReymondF Köckerling
Mar 10, 2001·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·W. Faught, M. Fung Kee Fung
Apr 26, 2003·Gynecologic Oncology·Carien L CreutzbergUNKNOWN PORTEC Study Group
Feb 27, 2004·Gynecologic Oncology·Andreas ObermairAnthony J McCartney
Dec 2, 2004·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P T RamirezC Levenback
Feb 18, 2005·European Urology·Ralph A HighshawSurena F Matin
Sep 5, 2006·The Oncologist·Alan C Schlaerth, Nadeem R Abu-Rustum
Oct 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alice B KornblithDavid Cella
Oct 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan L WalkerSudarshan K Sharma
May 11, 2010·Gynecologic Oncology·A MartínezG Ferron
Jul 20, 2010·The Lancet Oncology·Marian J E MouritsGeertruida H de Bock
Feb 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joan L WalkerSudarshan K Sharma
Jul 4, 2012·Journal of Minimally Invasive Gynecology·Stefano PalombaGiovanni Battista La Sala
Jan 1, 2011·Gynecologic Oncology Case Reports·Stefano PalombaFulvio Zullo

❮ Previous
Next ❯

Citations

Mar 24, 2017·Gynecologic Oncology Reports·Uma DeshmukhMasoud Azodi
May 7, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Blanca SegarraPriya Bhosale
Oct 30, 2020·Cancer Management and Research·Qianqian GaoBo Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.